Brighten Collection

PEP-5 Brightening Eye Gel

An eye gel that targets dark circles, under-eye puffiness and periorbital discolouration through five pathways — vascular, oxidative, pigment, structural and fluid.

Brightens
De-puffs
Targets Dark Circles
PEP-5 Brightening & De-Puff Eye Gel
PEP-5 Brightening & De-Puff Eye Gel
With REGU-AGE® · Hesperidin Methyl Chalcone · Pep-Eye® · Niacinamide
$00.00 NZD / —ml
Size
Brightens
De-puffs
Dark Circles
  • Skin concerns: dark circles, under-eye puffiness, periorbital discolouration.
  • Skin type: all skin types — formulated for the periorbital area; patch test first.
  • Scent: fragrance-free.
  • Texture: light water-gel serum with a silky finish.
  • pH: 5.5–5.7.

An eye gel formulated to target the three pathways known to cause discolouration and puffiness around the eye.

Vascular. The most common type. Haemoglobin pools beneath thin periorbital skin and oxidises to dark pigments — creating the characteristic blue, purple or red discolouration. REGU-AGE® improves microcirculation and protects the capillary matrix through enzyme inhibition. Hesperidin Methyl Chalcone (orange peel extract) strengthens capillary walls and directly inhibits the oxidation of haemoglobin to the compounds that cause discolouration. Encapsulated caffeine promotes vasoconstriction to reduce visible vessel engorgement.

Pigmentation. Melanin accumulates in the periorbital skin — common after UV exposure, inflammation, or in darker skin tones. Niacinamide inhibits melanosome transfer: the step at which melanin moves from melanocytes to surrounding skin cells. Clinical studies confirm 35–68% inhibition of this transfer.

Structural. Weakened connective tissue and fluid retention create puffiness and deepen the shadow beneath the eye. REGU-AGE® inhibits collagenase and elastase — the enzymes that break down the connective tissue matrix. Pep-Eye® (Acetyl Tetrapeptide-5) reduces capillary permeability through ACE inhibition to limit fluid accumulation, and inhibits glycation of structural proteins to preserve the collagen network.

Anyone with dark circles, puffiness or discolouration around the eye — or targeted dark patches elsewhere on the face. Suitable for all skin types. Fragrance-free.

  • REGU-AGE® — a complex of purified soy and rice peptides with biotechnologically produced Superoxide Dismutase. Targets periorbital dark circles through free-radical neutralisation, collagenase and elastase inhibition, and measurable improvement in capillary microcirculation. In a double-blind in vivo study, 5% REGU-AGE® produced a 32% reduction in dark circles and 25% reduction in puffiness at four weeks.
  • Hesperidin Methyl Chalcone — a bioflavonoid derived from citrus (orange) peel that works directly on the capillary endothelium. Reduces capillary filtration and inhibits the oxidation of leaked haemoglobin to biliverdin and bilirubin — the compounds that create the blue-purple colour of vascular dark circles. Addresses the colour at its source.
  • Pep-Eye® (Acetyl Tetrapeptide-5) — a synthetic tetrapeptide developed specifically for the under-eye area. Reduces capillary permeability through ACE inhibition and inhibits protein glycation to preserve the skin's structural network. Clinical data: 70% of subjects showed ≥30% puffiness volume reduction at 15 days; 95% showed measurable improvement at 60 days.
  • Encapsulated Caffeine — caffeine delivered via cyclodextrin encapsulation for enhanced penetration. Works through adenosine receptor antagonism and phosphodiesterase inhibition to promote lymphatic drainage and reduce visible puffiness.
  • Niacinamide — addresses the pigment-pathway component of dark circles by inhibiting the transfer of melanin-containing melanosomes to neighbouring keratinocytes (35–68% inhibition in clinical models). Formulated at 2%, calibrated for the thinner periorbital skin.

Morning and evening, as the last step before eye cream, moisturiser or SPF.

Routine order: Cleanse → Tone → Serum → Eye Gel → Eye Cream → Moisturiser → SPF.

AM — pat a small amount onto the orbital bone area using your ring finger. Allow to absorb fully before SPF or moisturiser.

PM — apply to the orbital bone area before your eye cream. Pat gently until absorbed.

Pro-Tips

  • Use your ring finger — it applies the least pressure.
  • Pat, don't rub.
  • Use morning and evening consistently — results build over weeks.

Storage: store in a cool, dry place away from heat and direct sunlight.

Cautions: patch test before first use. For external use only. Avoid direct contact with eyes — if contact occurs, rinse thoroughly with water. Apply to the orbital bone area only; do not apply to the eyelid or within 1cm of the lash line. Discontinue use if irritation occurs. Keep out of reach of children.

Aqua, Cucumis Sativus (Cucumber) Fruit Water, Glycerin, Niacinamide, Polyacrylate Crosspolymer-6, Hesperidin Methyl Chalcone, Lauryl PEG/PPG-18/18 Methicone, Sodium PCA, Phenoxyethanol, Cyclodextrin, Caffeine, Hydrolyzed Rice Bran Protein, Sodium Phytate, Ethylhexylglycerin, Superoxide Dismutase, Glycine Soja (Soybean) Protein, Sodium Benzoate, Acetyl Tetrapeptide-5.

Fragrance-free. pH 5.5–5.7.

Dark circles have multiple overlapping causes: blood pooling and haemoglobin oxidation under thin skin (vascular), melanin accumulation at the surface (pigment), weakened capillary and connective tissue structure, and fluid retention causing puffiness. This gel targets all five — vascular, oxidative, structural, fluid accumulation, and melanin — simultaneously using five distinct actives.

Clinical data for the key actives shows visible improvement from 15 days with consistent twice-daily use, and a 32% reduction in dark circles at four weeks for REGU-AGE®. Vascular mechanisms respond relatively quickly; pigment changes take longer. Use consistently morning and evening.

Yes. While developed for the orbital area, the actives — particularly Niacinamide, Hesperidin Methyl Chalcone and encapsulated caffeine — work on the same pigment and vascular mechanisms anywhere on the face. Use it as a targeted treatment on areas of discolouration beyond the eye.

Yes. The formula is fragrance-free, contains no essential oils, and is pH balanced at 5.5–5.7. Patch test before first use.

The Eye Gel is the active treatment step — fast-absorbing, targeting dark circles and puffiness through five mechanisms. The Eye Cream follows as the nourishing step, providing comfort and sustained support for periorbital skin. Apply gel first, cream second.

No — fragrance-free.

Ingredient Spotlight

Five actives. Five pathways to brighter eyes.

REGU-AGE — soy and rice peptide complex

REGU-AGE®

Soy & Rice Peptides + Superoxide Dismutase

Improves microcirculation and protects the periorbital matrix — 32% dark circle and 25% puffiness reduction at four weeks.

Hesperidin Methyl Chalcone — citrus bioflavonoid

HESPERIDIN METHYL CHALCONE

Citrus (Orange Peel) Bioflavonoid

Strengthens capillary walls and stops haemoglobin oxidising to the blue-purple compounds behind vascular dark circles.

Pep-Eye — Acetyl Tetrapeptide-5

PEP-EYE®

Acetyl Tetrapeptide-5

Reduces capillary permeability and fluid leakage — 70% of subjects saw ≥30% less puffiness at 15 days.

Niacinamide — Vitamin B3

NIACINAMIDE

Vitamin B3 (2%)

Inhibits melanosome transfer to even periorbital pigment — 35–68% inhibition in clinical models.

  1. DSM Nutritional Products. REGU®-AGE PF — in vivo efficacy. Double-blind, n=20, 5% REGU-AGE® cream, 8 weeks. 32% dark circle reduction, 25% puffiness reduction at 4 weeks. DSM data on file.
  2. Sisneo Bioscience. Hesperidin Methyl Chalcone — mechanism and capillary filtration data. Capillary wall integrity and haemoglobin oxidation inhibition. Industry formulation data.
  3. Lipotec/Lubrizol. Pep-Eye® (Acetyl Tetrapeptide-5) — ACE inhibition, anti-glycation, anti-puffiness. n=20 subjects, 60-day twice-daily application. Supplier data on file.
  4. Cappelletti S, et al. Caffeine: cognitive and physical performance enhancer or psychoactive drug? Curr Neuropharmacol. 2015;13(1):71–88. doi: 10.2174/1570159X13666141210215655.
  5. Hakozaki T, Minwalla L, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20–31. PMID: 12100180.
  6. Greatens A, Hakozaki T, et al. Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible. Exp Dermatol. 2005;14(7):498–508. PMID: 15946237.
  7. Pissaridou MK, Ghanem A, Lowe N. Periorbital Discolouration Diagnosis and Treatment: Evidence-Based Review. J Cosmet Laser Ther. 2021;22(6-8):217–225. PMID: 34078228.